Huapont Life Sciences News

Huabang Health: 002004 Huabang Health Investor Relations Management Information 20241129

Nov 28 21:48 ET

Huabang Health: Announcement on participating in the 2024 Online Investor Group Reception Day for Listed Companies in Chongqing

Nov 22 11:00 ET

Huabang Health: Announcement of Board Resolutions

Oct 28 12:00 ET

Huabang Health: Public Opinion Management System (October 2024)

Oct 28 12:00 ET

Huabang Health: Voluntary Information Disclosure Notice on Keji Dalong Obtaining an Agricultural Genetically Modified Biosafety Certificate

Oct 14 12:00 ET

Huapont Life Sciences: 002004 Huabang Health Investor Relations Management Information 20240429

Apr 29 06:18 ET

Huapont Life Sciences: The Board's Special Opinions on Evaluating the Independence of Independent Directors

Apr 26 12:00 ET

Huapont Life Sciences: Report on the work of the Board of Supervisors for the year 2023

Apr 26 12:00 ET

Huapont Life Sciences: Announcement of Board Resolutions

Apr 26 12:00 ET

Huapont Life Sciences: Announcement on the renewal of the 2024 Audit Institution

Apr 26 12:00 ET

Huapont Life Sciences: Internal Control Audit Report

Apr 26 12:00 ET

Huapont Life Sciences: 2023 Annual Audit Report

Apr 26 12:00 ET

Huapont Life Sciences: Independent Director's 2023 Debriefing Report - Liu Zhonghai

Apr 26 12:00 ET

Huapont Life Sciences: Announcement of Supervisory Board Resolutions

Apr 26 12:00 ET

Huapont Life Sciences: 2023 Board Work Report

Apr 26 12:00 ET

Huapont Life Sciences: Independent Director's Annual Debriefing Report

Apr 26 12:00 ET

Huapont Life Sciences: Annual special audit report on the expenditure of related parties' funds

Apr 26 12:00 ET

Huabang Health: Announcement of Resolutions of the 17th Meeting of the Eighth Board of Directors

Mar 7 11:00 ET

Huabang Health: Announcement of Resolutions of the 16th Meeting of the Eighth Board of Directors

Dec 27, 2023 11:00 ET

Huabang Health: Rules of Procedure for Shareholders\' Meeting (December 2023)

Dec 4, 2023 11:00 ET